NIH hopes to win over skeptics with drug repurposing successes

07/18/2013 | Nature (free content)

Nine awardees will split $12.7 million from the NIH to find new targets for eight abandoned drug compounds. Critics say the National Center for Advancing Translational Sciences program has low odds of succeeding because drugmakers that developed the compounds abandoned them for a reason. Proponents say even moderate success will yield substantial return on the investment.

View Full Article in:

Nature (free content)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN